Neuro-Oncology
A poptosis, or programmed cell death, is a physiologic mechanism designed to eliminate unwanted cells from the body (Raff et al., 1992) . Considerable evidence has shown that apoptotic cells can be recognized and engulfed by either surrounding cells (Gobe et al., 1987) or professional phagocytes such as macrophages (Wyllie et al., 1980) . Phagocytosis of apoptotic cells has been suggested to be a safe way to remove unwanted cells without exposing the adjacent tissues to in ammatory molecules. For example, the engulfment of apoptotic lymphocytes by macrophages prevents the release of proin ammatory tumor necrosis factor-a and instead stimulates the release of immunosuppressive interleukin-10 from macrophages (Voll et al., 1997) . The phagocytic clearance of apoptotic bodies is important in several physiologic events including in ammatory resolution (Savill et al., 1989) , thymic involution (Surh et al., 1994) , and tissue homeostasis (Savill et al., 1993) .
Despite the physiologic importance of phagocytosis of apoptotic cells, the events that trigger phagocytosis remain largely unknown. Phagocytosis appears to require the expression of speci c receptors on the phagocytes as well as changes in the membrane of the soon-to-beengulfed apoptotic cells. The receptors thought to be involved in phagocytic recognition of apoptotic cells are varied and include lectin (Dini et al., 1995) , CD14 (Devitt et al., 1998) , vitronectin a v b 3 /CD36 (Fadok et al., 1998) , and ATP-binding cassette 1 systems (Luciani et al., 1996) . Changes on the cell membranes of apoptotic cells suggested to be key in inducing phagocytosis are also varied and include the presence of glycosylation (Dini et al., 1995) , creation of thrombospondin-1 bindPhosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells ing sites (Savill et al., 1992) , and loss of membrane phospholipid asymmetry (Fadok et al., 1992) . PS, 2 an anionic aminophospholipid normally located at the inner lea et of the plasma membrane, is currently the best characterized marker for phagocytic recognition. The exposure of PS at the outer membrane lea et appears to be a general feature of apoptosis (Martin et al., 1995) and the exposed PS plays an essential role in phagocytic recognition. For example, phagocytosis of erythrocytes and apoptotic lymphocytes can be inhibited by the preincubation of macrophages with liposomes containing PS, but is not affected by liposomes containing other anionic phospholipids such as PC (Fadok et al., 1992) . Apoptotic vascular smooth muscle cells pretreated with annexin-V, which speci cally binds to PS, are not phagocytosed by normal smooth muscle cells (Bennet et al., 1995) . The exposure of PS is attributed to the coordinated activities of AT and the enzyme scramblase in apoptotic cells (Bevers et al., 1999) . AT, as its name suggests, speci cally recognizes aminophospholipids as its substrates, transferring PS, and to some extent, phosphatidylethanolamine, from the outer lea et to the inner lea et (Zachowski et al., 1986) . Scramblase, on the other hand, mediates the bidirectional transverse movement of all plasma phospholipids across the membrane bilayer in a nonspecific fashion, including the rather inert PC, which usually resides at the outer lea et of the membrane (Basse et al., 1996) . During apoptosis, scramblase activity is increased, whereas AT activity is suppressed, resulting in PS exposure at the cell surface. Furthermore, the loss of AT activity alone is not suf cient to induce PS appearance during apoptosis when scramblase activity is blocked, suggesting that the induction of scramblase activity is critical for PS exposure (Bratton et al., 1997) .
Although the processes of apoptosis and phagocytosis appear to be intimately linked, recent evidence suggests that the pathways regulating apoptosis and phagocytosis are in fact independent and separable. For example, human monocytic THP.1 cells treated with inhibitors blocking PS externalization can still undergo apoptosis without being phagocytosed by macrophages (Zhuang et al., 1998) . Conversely, in transgenic mice that overexpress bcl-2, phagocytic removal of aging neutrophils by macrophages occurs even though the apoptosis of neutrophils is blocked (Lagasse et al., 1994) . These data suggest that, although apoptosis normally precedes phagocytosis, the removal of cells can proceed in the absence of apoptotic signals.
The potential for removing unwanted cells, such as tumor cells, by phagocytosis is of therapeutic interest, particularly in the treatment of gliomas. Gliomas are among the most malignant tumors, with a median survival rate of less than 2 years. Chemotherapy in conjunction with surgical removal and irradiation to treat gliomas is of marginal use (Hosli et al., 1998) . Gliomas, however, are surrounded by NHA and are known to be in ltrated with microglia, the CNS equivalent of macrophages (Lorusso et al., 1997) . As both NHA and microglia have been shown to help remove cell debris and myelin in certain CNS disorders (Smith, 1999; Thomas et al., 1992; and Vinores et al., 1993) , the possibility exists that the phagocytic ability of these cells could be directed toward glioma cells, even in the absence of apoptosis of the glioma. To address this possibility, we first examined whether astrocytes and microglia had phagocytic activity. We then addressed the speci city of the phagocytosis process and the signals involved in triggering phagocytosis of apoptotic glioma cells.
Materials and Methods

Cell Line and Cell Culture
NHAs were obtained from Clonetics (Walkersville, Md.). U-87 MG, U-251 MG, and SF268 cell lines were obtained from Brain Tumor Research Center, University of California at San Francisco. NHAs were cultured in the media made from an AGM Bullet Kit (Clonetics), and the media was changed every other day. Other glioma cells were cultured in DMEM supplemented with 20% bovine calf serum, 20 mM Hepes, and penicillin, streptomycin, and gentamicin (University of California at San Francisco Cell Culture Facility). Cells were maintained in a 37°C, 5% CO 2 , humidi ed incubator.
Microglial Culture
Fresh human brain tissue was obtained from a patient undergoing epilepsy surgery. There was no evidence of neoplastic cells on pathologic examination of the tissue obtained at the time of surgery. Brain tissue was minced and digested for 90 min at 37°C in DMEM containing 0.25% trypsin, 50 mg/ml DNase, and 50 mg/ml gentamicin. The cell suspension was ltered through a 100-mm nylon mesh, and then the cells were pelleted by centrifugation at 1500 rpm for 10 min. The cell pellet was resuspended with 30% Percoll (Sigma, St. Louis, Mo.) in PBS and centrifuged at 17,500g for 30 min to form a gradient. The upper layer of the gradient was discarded, while the central part containing mainly microglia and oligodendrocytes was collected and washed twice with PBS. Cells were then cultured in DMEM with 20% bovine calf serum, 20 mM Hepes, and penicillin, streptomycin, and gentamicin. After 48 h of incubation, nonadherent oligodendrocytes were discarded. Attached microglial cells were washed with PBS 3 times and replenished with fresh culture media. The cells were then positively identi ed as microglia by the uptake of uorescent di-acylated LDL (Molecular Probes, Eugene, Ore.) as follows: cells were split and 10 4 cells were put into a 4-well chamber slide overnight to allow attachment. Then cells were washed twice with PBS, followed by the addition of 15 mg/ml di-acylated LDL in 0.1% bovine serum albumin in DMEM. Internalization of di-acylated LDL was allowed to occur for 3 h at 37°C, after which the cells were washed, xed in 4% paraformaldehyde, and monitored using a uorescent microscope for the uptake of uorescent di-acylated LDL. Only those cells able to internalize di-acylated LDL were used in further studies. All microglial cells in culture displayed an ameboid morphology.
Apoptosis Induction and Measurement
U-251 MG cells were made apoptotic by treatment with 25 mg/ml etoposide (Clontech) for 24 h. NHA, U-87 MG, and SF268 cells were resistant to etoposide-induced apo-ptosis and were made apoptotic by incubation with 1 mM H 2 O 2 for 24 h. Cells were collected and assessed for apoptosis using both annexin-V-FITC binding and TUNEL assays. The annexin-V-FITC binding assay was done using an ApoAlert Annexin V kit (Clontech). After drug treatment, cells were washed with PBS and trypsinized. Cells were rinsed with and then suspended in 1´binding buffer (200 ml/10 6 cells). Five microliters of annexin-V-FITC was then added to the cell suspension and the solution was incubated at room temperature for 15 min in the dark. Binding buffer (1´) was added to bring the nal volume to 0.5 ml, and the cell suspension was analyzed by ow cytometry to assess the binding of the uorescent annexin-V-FITC to the cell surface. For uorescence microscopy observation of apoptosis, cells were grown directly on glass slides and rinsed with 1´binding buffer. Five microliters of annexin V-FITC and 10 ml of propidium iodide in 200 ml of 1´binding buffer were then added onto the slide and incubated for 15 min in the dark. Cells were observed under a uorescent microscope, with apoptotic cells being considered to be those cells which stained positive for annexin V-FITC at the cell membrane. Propidium iodide, a membrane-impermeable DNA-binding dye, was used to identify the early and late stages of apoptotic cells. Early apoptotic cells, which still have intact membranes, exclude propidium iodide, whereas late apoptotic cells, in which the membrane integrity is partially lost, should stain positive for propidium iodide at the nucleus.
The TUNEL assay was done using a ApoAlert DNA fragmentation assay kit (Clontech) and was based on the ability of terminal deoxynucleotidyl transferase to catalyze the incorporation of uorescent dUTP-FITC at the free 3¢-hydroxy ends of fragmented DNA in the nucleus. Cells were grown on glass slides and, after apoptosis induction, were washed with PBS and then xed with fresh 4% formaldehyde/PBS at 4°C for 25 min. Cells were then washed with PBS 3 times and permeabilized with prechilled 0.2% Triton X-100/PBS on ice for 10 min. Slides were then washed with PBS 3 times and equilibrated in 100 ml of equilibration buffer for 10 min at the room temperature. A solution composed of 1 ml terminal deoxynucleotidyl transferase, 5 ml of nucleotide mix containing FITC-conjugated dUTP, and 45 ml of equilibration buffer was then added on a slide. The tailing reaction was performed by placing the slides in a dark humidi ed 37°C incubator for 60 min. Slides were immersed in 2´saline-sodium citrate to terminate the tailing reaction after which the attached cells were washed with PBS 4 times and stained with propidium iodide (0.5 mg/ml) or ¢,6-diamidino-2-phenylindole (250 ng/ml) at room temperature for 10 min. Cells were then washed with PBS twice and with water twice. A drop of antifade (2.3% 1,4-diazobicyclo[2.2.2]octane, 90% glycerol in PBS) was added on top of each slide, and cells were observed immediately under a uorescent microscope to look for the appearance of the green uorescent dUTP-FITC at the nucleus.
In Vitro Phagocytosis Assay
Two days before the assay, 10 4 of the phagocytes to be tested (NHA, microglia, or glioma cells) were placed into a 35-mm tissue culture dish. Meanwhile, glioma cells were treated with various apoptosis-inducing agents (etoposide or H 2 O 2 as described above). Apoptotic bodies were collected, washed 3 times with PBS, and resuspended in culturing media with serum (4 ´10 5 cells/ml). One milliliter of apoptotic cell suspension was then added onto each plate containing approximately 10 4 phagocytes. For experiments with annexin-V preincubation, recombinant annexin-V (PharMingen, San Diego, Calif.) at a concentration of 0.25 mg/10 4 cells was added to the apoptotic bodies 30 min before loading apoptotic bodies onto the phagocyte monolayer. Phagocytosis was allowed to proceed in a 37°C humidi ed incubator for 3 h. The nonphagocytosed cells were then washed off with PBS 5 times. Adherent cells were then xed with 4% formaldehyde/PBS for 30 min, washed with PBS twice, and then stained with crystal violet solution (0.5% crystal violet in 20% methanol) for visualization under a microscope. A minimum of 100 phagocytes were counted in random elds from at least 4 independent areas of each dish. PI was determined by multiplying the percentage of phagocytes that had engulfed apoptotic bodies by the average number of phagocytosed bodies per phagocyte.
Scramblase Activity
The activity of scramblase was determined by the internalization of fluorescent NBD-PC (Avanti, Alabaster, Ala.) during the course of apoptosis of glioma cells. One microgram of NBD-PC was dissolved in 20 ml of Hepesbuffered saline (137 mM NaCl, 2.7 mM KCl, 2 mM MgCl 2 , 5 mM glucose, 10 mM Hepes pH 7.4, and 2 mM CaCl 2 ) with 200 mM fresh phenylmethylsulfonyl uoride and 0.25% lipid-free bovine serum albumin (Sigma). Cells were collected at different time points after apoptosis induction, washed with PBS once, and resuspended in Hepes-buffered saline (10 7 cells/ml). The cell suspension (50 ml) was then incubated with 2 ml of NBD-PC lipid solution for 10 min at room temperature. Cells were pelleted by centrifugation at 3000 rpm for 5 min, and the supernatant was discarded. Albumin extraction of the plasma membrane outer lea et was performed by adding 50 ml of 1% bovine serum albumin/Hepes-buffered saline to the cells for 5 min at the room temperature to remove uorescent lipid that had not entered the cells. Cells were pelleted by centrifugation at 3000 rpm for 5 min and the supernatant was removed. Ice-cold Hepes-buffered saline (0.9 ml) was then added to the cell pellets, and flow cytometry analysis was performed within 2 h to measure the ability of scramblase to transfer the exogenous uorescent NBD-PC into the cells.
Western Blotting
SF268, U-87 MG, and U-251 MG cells were lysed using radioactive immuno-protection assay solution (1% Nonidet P-40 , 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate in PBS) with freshly added phenylmethylsulfonyl uoride, leupetin, aprotinin, sodium orthovanadate, and phosphatase inhibitor. Cell lysates were centrifuged at 14,000 rpm for 10 min and the supernatants were collected. Cellular proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (25 mg/lane), and the protein samples were transferred onto a nitrocellulose membrane (Millipore, Marlborough, Mass.). The membrane was incubated with the blocking solution (5% nonfat dry milk in Tris-buffered saline with 0.5% NP-40) for 1 h. Then the membrane was incubated with the rabbit antiscramblase antibody (Oncogene, Cambridge, Mass.) at a concentration of 2 mg/ml for 2 h. The membrane was washed 3 to 4 times for 10 min in Tris-buffered saline with 0.5% NP-40. Subsequently, the membrane was incubated with horseradish peroxidase-conjugated secondary donkey antirabbit IgG (1:5000) (Jackson ImmunoResearch, Ft. Lauderdale, Fla.) for 90 min. The membrane was washed 3 times in Tris-buffered saline with 0.5% NP-40 and was then treated with enhanced chemiluminescence reagent (NEN, Boston, Mass.) for 1 min. The proteins were detected by autoradiography. Equal protein loading was con rmed by Coomassie blue staining of the polyacrylamide gel and by Ponseau S staining of the blotted membrane.
Results
Apoptotic Pro le of Glioma Cells
Etoposide (25 mg/ml) was used to induce apoptosis of U-251 MG glioma cells, whereas H 2 O 2 (1 mM) was used to induce apoptosis in U-87 MG and SF268 cell lines. Both annexin-V-FITC and TUNEL assays were used to measure apoptosis after 24 h of drug administration in various glioma cells. annexin-V-FITC labeling was monitored by both uorescence microscopy and ow cytometry, whereas the results from TUNEL assay were assessed by uorescence microscopy. After 24 h of etoposide treatment, apoptotic U-251 MG cells showed strong green uorescent annexin-V-FITC staining at the plasma membrane (Fig. 1A) . Both early (propidium iodide-negative) and late (propidium iodide-positive, with strong nuclear staining of red uorescence) stages of apoptotic cells were observed (Fig. 1A) . Annexin-V-FITC staining was also analyzed by ow cytometry, with the data plotted as cell number (y-axis) against the green annexin-V-FITC uorescence (x-axis). After etoposide treatment, U-251 MG cells showed a sharp peak of annexin-V-FITC uorescence as compared with low annexin-V-FITC intensity in untreated U-251 MG cells (Fig. 1B) . TUNEL assay showed that apoptotic U-251 MG cells exposed to etoposide for 24 h incorporated dUTP-FITC and stained green (Fig. 1C, left panel) . Similarly, after 24 h of H 2 O 2 addition, both annexin-V-FITC and TUNEL assays demonstrated that apoptosis occurred in both U-87 MG cells ( Fig. 1D and E, respectively) and in SF268 cells (data not shown). These apoptotic cells were collected and used in in vitro phagocytosis assays.
Phagocytosis of Apoptotic Glioma Cells by NHA, Microglia, and Glioma Cells
Next, we assessed the ability of NHA, U-251 MG, and microglial cells to recognize and phagocytose apoptotic U-251 MG cells. PI was calculated as described, and the PI of NHA was normalized to 100% and used as the control. When incubated with apoptotic U-251 MG cells, both NHA and microglia phagocytosed apoptotic glioma cells (Fig. 2 A and B) . We then compared the phagocytic ability of NHA with that of microglia. As shown in Fig.  2C , the PI of microglia was approximately 4-fold higher than that of NHA, demonstrating that microglia were more ef cient in phagocytosing apoptotic glioma cells. This is probably due to the ability of microglia to take up more apoptotic bodies per cell than NHA ( Fig. 2A and  2B ). On the other hand, U-251 MG cells had little phagocytic activity against their apoptotic selves, with a PI of only 4% (Fig. 2D) . One possible explanation is that glial cells, including normal cells and cancerous cells, are blocked in their ability to phagocytose apoptotic cells of the same type. Alternatively, glioma cells may lack the ability to phagocytose apoptotic cells. To address the rst possibility, NHA were made apoptotic by treatment with H 2 O 2 for 24 h at a concentration of 1 mM. Apoptosis was con rmed by both TUNEL and annexin-V binding assays (data not shown). The PI value of NHA engul ng apoptotic NHA, however, was not signi cantly different from that of NHA phagocytosing apoptotic glioma cells (Fig. 3) , ruling out the possibility that glial cells can't phagocytose apoptotic cells of the same type. To investigate whether all glioma cells lack the ability to perform phagocytosis, U-87 MG cells and SF268 cells were presented with apoptotic U-251 MG cells. Both U-87 MG and SF268 glioma cell lines recognized and engulfed apoptotic U-251 MG cells (PI = 54% for SF268 and 62% for U-87 MG), although their ability to phagocytose was not as great as that of NHA (Fig. 4A) . In contrast, the U-251 MG cells incubated with a variety of apoptotic cells showed low PI values compared with that of the negative control group (in vitro phagocytosis assay of normal U-251 MG cells in the absence of apoptotic cells, Fig. 4B ), indicating that U-251 MG cells were unable to perform phagocytosis. These results demonstrate that NHA, microglia, and the glioma cells tested (except U-251 MG cells) were able to phagocytose apoptotic bodies, with microglia being the most ef cient, followed by NHA, and then glioma cells. U-251 MG cells were unique in their inability to phagocytose a variety of apoptotic cells.
Phagocytosis by NHA and Microglia is Speci c for Apoptotic Cells
As microglia, and to some extent NHA, are considered to be scavenger cells, we questioned whether phagocytosis by these cells was speci c to apoptotic cells or was simply a generalized response to dead cells. To address this issue, nonadherent, dead, oating U-251 MG cells were collected after cells were plated. Annexin-V binding and TUNEL assays both showed that these oating cells were nonapoptotic dead cells (data not shown). These nonapoptotic dead cells were then used to test the phagocytosis speci city of NHA and microglia. Fig. 5 shows that both NHA and microglia showed some phagocytic activity against nonapoptotic dead glioma cells. The PI values using nonapoptotic cells were approximately 80% less than the values obtained using apoptotic cells. Thus, NHA and microglia phagocytosed apoptotic cells far better than they phagocytosed nonapoptotic dead cells. The phagocytic ability of NHA and microglia is therefore not a generalized response to dead cells.
Effect of PS Exposure on Phagocytosis by NHA and Microglia Cells
Like most apoptotic cells, apoptotic glioma cells exhibit PS at the cell surface (Fig. 1A) . If PS appearance at the apoptotic cell surface is required for phagocytic recognition in glial cells, then complexing PS with annexin-V should prevent the phagocytic recognition by NHA and microglia. To assess the role of PS exposure, apoptotic glioma cells were preincubated with recombinant annexin-V protein for 30 min before the in vitro phagocytosis assay. As shown in Fig. 6 , the addition of annexin-V inhibited 90% of phagocytosis of apoptotic U-251 MG cells by both NHA and microglia. These results suggest that the glial phagocytosis involves PS exposure at the membrane of apoptotic cells.
Scramblase Activity and Expression in Glioma Cells
Scramblase activity has been shown to be required for the PS appearance at the apoptotic cell surface, and its expression has been found in various human cell lines (Zhou et al., 1997) . We assessed whether scramblase was also expressed in glioma cells and whether scramblase activity was increased during apoptosis. Western blotting of scramblase expression in U-87 MG, U-251 MG, and SF268 cells showed that U-251 MG cells had the highest scramblase protein expression among the glioma cells tested, whereas both U-87 MG and SF268 cells have very little scramblase expression (Fig. 7) . Scramblase activity was assessed by measuring its ability to mediate the bidi- rectional transverse movement of plasma phospholipids across the membrane bilayer. Fluorescent NBD-PC was used as the substrate for scramblase and was added exogenously to drug-induced apoptotic cells. The appearance of NBD-PC at the inner lea et of the plasma membrane within 24 h after administration of the apoptosis-inducing agents was measured by ow cytometry. The cell number (y-axis) was then plotted against the fluorescent intensity of NBD-PC inside the apoptotic cells (x-axis). As shown in Fig. 8 , in U-251 MG cells and U-87 MG cells undergoing apoptosis, scramblase activity was elevated in a time-dependent manner, with an increase of scramblase activity seen at 16 h after drug treatment. These results suggest that the phagocytosis process induced by PS exposure in apoptotic glial cells is associated with increase in scramblase activity.
Discussion
In this study, microglia, NHA, and the glioma cells tested (except U-251 MG cells) were all able to phagocytose apoptotic cells. Moreover, both NHA and microglia selectively phagocytosed apoptotic but not nonapoptotic glioma cells. Among the cells tested, microglial cells were the most effective phagocyte, with an approximate 4-fold higher PI than NHA. In addition, phagocytosis by both NHA and microglia was dependent on the presence of PS at the surface of apoptotic glioma cells. The activity of scramblase, an enzyme crucial in PS exposure, was also elevated during the apoptotic process of glioma cells, implying its involvement in PS appearance. These results suggest that NHA, and to an even greater extent microglia, can remove neighboring apoptotic cells, including malignant glioma cells. The possibility exists that phagocytosis might be effective in removing glioma cells. If phagocytosis of tumor cells were to be a viable approach in tumor treatment, microglial cells would be a logical effector cell. Microglia have been shown to phagocytose apoptotic neuronal cells in vitro with high efciency (Adayev et al., 1998) , and in this report, we note that microglial cells were the most ef cient phagocyte among a variety of cells tested. Because all experiments in the present report were performed in in vitro conditions, in which microglial cells are known to be activated and capable of phagocytosis, one can argue that microglial cells residing in gliomas in vivo may not be in an active state. Indeed, resting rami ed microglia, characterized by the loss of macrophage-like properties, are the major type of microglial cells in normal adult brains (Murabe et al., 1982) . However, under pathologic conditions such as ischemia, in ammation, and degenerating diseases, ramied microglia can rapidly transform into active ameboid microglia capable of secreting various cytokines, expressing macrophage markers, and performing phagocytosis (Gehrmann et al., 1995) . Because both the resting rami ed type and active ameboid type of microglial cells are present in high-grade gliomas (Roggendorf et al., 1996) , it is likely that microglial cells in ltrating gliomas in vivo are active and able to phagocytose appropriate targets. The use of phagocytosis in the therapy of tumors has, in fact, been suggested (Ma et al., 1998) , although in those studies drug-laden endothelial cells were used in hope of delivering cytotoxic agents to the tumor. An alternative phagocytosis approach might be to alter tumor cells so that they become better targets themselves for phagocytosis. The present studies suggest that the creation of glioma targets for phagocytosis would involve PS exposure and an increase in scramblase activity. Previous studies suggested that PS externalization is achieved through the balance of activities of AT and scramblase (Bevers et al., 1999) . However, recently it was reported that loss of AT activity alone was not enough to result in PS exposure, suggesting that scramblase activation is the driving force for PS appearance upon apoptotic stimulation (Bratton et al., 1997) . Scramblase is a 35-kDa protein found in a variety of cell lines and different tissues including spleen, thymus, colon, and prostate (Zhao et al., 1998) . It mediates the bidirectional transbilayer movement of plasma phospholipids to cause PS exposure when activated. Scramblase activity can be induced by increasing intracellular Ca 2+ concentration or by acidi cation of the cells to pH less than 6 . The level of scramblase expression has been shown to determine the extent of PS exposure upon Ca 2+ stimulation (Zhao et al., 1998) . This suggests that PS appearance at the cell surface could be manipulated by selectively increasing scramblase expression. However, because stimulation of scramblase activity by increasing Ca 2+ concentration or lowering intracellular pH may be dif cult to accomplish selectively under physiologic conditions, selective delivery and expression of a constitutively active scramblase in tumor cells might be a more reasonable approach. Our nding that scramblase was also expressed in glioma cells and activated during apoptosis indicates that phagocytosis can be triggered by manipulating scramblase activity to induce PS exposure at the glioma cell surface. A limited amount of structure/function information exists on scramblase, and a motif that mediates the Ca 2+ -accelerated phospholipid transbilayer movement has been identi ed . More information about the scramblase protein might allow the creation of an enzyme which, rather than being activated by increasing Ca 2+ concentration or lowering intracellular pH, is constitutively active. This constitutively active enzyme, if delivered appropriately, could then induce PS externalization and trigger phagocytosis by either the in ltrating microglial cells or the surrounding NHA.
Current therapies against gliomas include surgical removal, irradiation, and chemotherapy. However, the prognosis of glioma patients is still poor, with a survival period less than 2 years for high-grade glioma patients Fig. 5 . Enhanced phagocytosis of apoptotic cells versus nonapoptotic cells by normal human astrocytes (NHA) and microglia. Nonapoptotic, dead, oating U-251 MG cells were added to either NHA or microglia. After 3 h, phagocytes were washed, xed, stained, and counted to determine the phagocytosis index (PI). PI was then compared with the phagocytosis index PI of either NHA or microglia phagocytosing apoptotic U-251-MG cells. The results are expressed as means ± SD for at least 4 replicate determinations for each experiment. a, signi cantly reduced (P < 0.05) from the group of NHA with apoptotic U-251 MG cells. b, signi cantly reduced (P < 0.05) from the group of microglia with apoptotic U-251 MG cells. was added to the apoptotic U-251 MG cells 30 minutes before the addition to the phagocyte monolayer. In vitro phagocytosis assay was then performed and phagocytosis index (PI) was measured. The results are expressed as means ± for at least 4 replicate determinations for each experiment. a, Signi cantly reduced (P < 0.05) from the group of normal human astrocytes (NHA) without annexin-V incubation. b, Signi cantly reduced (P < 0.05) from the group of microglia without annexin-V incubation. Fig. 7 . Western blot of scramblase protein expression in various glioma cell lines. The expression of scramblase protein was analyzed by Western blotting with a rabbit antibody against human scramblase (2 mg/ml). Each lane contains 25 mg total protein extract, and equal loading was con rmed by Coomassie blue staining of the polyacrylamide gel and by Ponseau S staining of the blotted membrane. after diagnosis. This is mainly due to the infiltrative behavior of malignant gliomas and the intrinsic resistance to both irradiation and cytotoxic drugs. Our ndings that a variety of cells present in and near glioma cells in vivo can eliminate glioma cells by PS-dependent phagocytosis suggest that manipulation of the phagocytosis process may be a promising direction in the treatment of gliomas.
